SLGL Stock Analysis: Buy, Sell, or Hold?
SLGL - Sol-Gel Technologies Ltd. Ordinary Shares
$69.29
-3.44 (-4.72%)
▼
5d:
-0.99%
30d:
-6.21%
90d:
-6.12%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 22, 2026
3d
Get Alerted When SLGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SLGL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SLGL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SLGL is currently trading at $69.28, which is considered oversold relative to its 30-day fair value range of $70.16 to $76.02.
Technical Outlook: Technically, SLGL is in a uptrend. Immediate support is located at $65.97, while resistance sits at $80.53. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: SLGL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $110.00 (+51.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SLGL is in a uptrend. Immediate support is located at $65.97, while resistance sits at $80.53. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: SLGL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $110.00 (+51.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$70.16 -
$76.02
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 51.3% below Wall St target ($110.00)
Trading Range Analysis
30-Day Trading Range
$70.16 -
$76.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$65.97
Resistance Level
$80.54
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.34
Wall Street Target
$110.00
(+51.3%)
Revenue Growth (YoY)
150.4%
Earnings Growth (YoY)
487.6%
Profit Margin
-31.6%
Share & Embed Analysis
Last updated: May 18, 2026 10:20 AM ET
Data refreshes hourly during market hours. Next update: 11:20 AM
Data refreshes hourly during market hours. Next update: 11:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLGL showing a specific setup today?
Insider Activity (6 Months)
12
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Opaleye Management Inc.
BUY
100 shares
2026-01-27
Opaleye Management Inc.
BUY
1151 shares
2026-01-23
Opaleye Management Inc.
BUY
2173 shares
2026-01-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 63 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$293 | 60 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 42 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 59 HOLD |
